Chisesi, T <br/><br/>
A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma.  [electronic resource] 

 -  European journal of cancer & clinical oncology  Apr 1988 
 - 681-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0277-5379 
<br/><br/><label>Standard No.: </label>10.1016/0277-5379(88)90299-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibiotics, Antineoplastic--adverse effects<br/>Daunorubicin--adverse effects<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Idarubicin<br/>Leukopenia--chemically induced<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Nausea--chemically induced<br/>Thrombocytopenia--chemically induced